• Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer

  • 2022/11/08
  • 再生時間: 30 分
  • ポッドキャスト

Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer

  • サマリー

  • Emeritus Professor Ian Frazer
    University of Queensland

    The future of cancer and medical research

    In this episode, RCA Chief Executive Richard Vines speaks to Professor Ian Frazer about:

    • Inventing the technology behind the world’s first cancer vaccine
    • Vaccine hesitancy, and the potential of other vaccines for cancer
    • What makes the Translational Research Institute so special
    • The interface between clinicians, scientists and patients in medical research
    • Our expanding understanding of cancer and targeted treatment
    • The experience of being Australian of The Year, and what he’s working on now
    • How the Medical Research Future Fund works
    • The alleged brain drain of medical researchers from Australia
    • The need to better embed medical research into the health system
    • How he sees medical research benefiting patients in 10 years’ time
    More about Emeritus Professor Ian Frazer

    Ian and his colleague co-invented the technology behind the world’s first cervical cancer vaccine.

    He is the founding CEO of the Translational Research Institute in Brisbane, heads a biotechnology company working on new vaccine technologies, and chairs the advisory board of the Medical Research Future Fund.

    続きを読む 一部表示

あらすじ・解説

Emeritus Professor Ian Frazer
University of Queensland

The future of cancer and medical research

In this episode, RCA Chief Executive Richard Vines speaks to Professor Ian Frazer about:

  • Inventing the technology behind the world’s first cancer vaccine
  • Vaccine hesitancy, and the potential of other vaccines for cancer
  • What makes the Translational Research Institute so special
  • The interface between clinicians, scientists and patients in medical research
  • Our expanding understanding of cancer and targeted treatment
  • The experience of being Australian of The Year, and what he’s working on now
  • How the Medical Research Future Fund works
  • The alleged brain drain of medical researchers from Australia
  • The need to better embed medical research into the health system
  • How he sees medical research benefiting patients in 10 years’ time
More about Emeritus Professor Ian Frazer

Ian and his colleague co-invented the technology behind the world’s first cervical cancer vaccine.

He is the founding CEO of the Translational Research Institute in Brisbane, heads a biotechnology company working on new vaccine technologies, and chairs the advisory board of the Medical Research Future Fund.

Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazerに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。